The global market for POC Lipid Testing was estimated at US$263.3 Million in 2023, and is projected to reach US$327.1 Million by 2030, growing at a CAGR of 3.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Hyperlipidemia Application segment, which is expected to reach US$97.0 Million by 2030 with a CAGR of a 2.9%. The Hypertriglyceridemia Application segment is also set to grow at 4.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $69.2 Million in 2023, and China, forecasted to grow at an impressive 5.4% CAGR to reach $70.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global POC Lipid Testing Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global POC Lipid Testing Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global POC Lipid Testing Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as A. Menarini Industrie Farmaceutiche Riunite Srl, Abaxis, Inc., Accutech LLC, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 42 Featured):
- A. Menarini Industrie Farmaceutiche Riunite Srl
- Abaxis, Inc.
- Accutech LLC
- Alere, Inc.
- Biochemical Systems International Srl
- Bio-Rad Laboratories, Inc.
- Eurotrol B.V.
- F. Hoffmann-La Roche AG
- General Life Biotechnology Co., Ltd.
- Helena Laboratories Corporation
- Nova Biomedical Corporation
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned
- A. Menarini Industrie Farmaceutiche Riunite Srl
- Abaxis, Inc.
- Accutech LLC
- Alere, Inc.
- Biochemical Systems International Srl
- Bio-Rad Laboratories, Inc.
- Eurotrol B.V.
- F. Hoffmann-La Roche AG
- General Life Biotechnology Co., Ltd.
- Helena Laboratories Corporation
- Nova Biomedical Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 192 |
| Published | December 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 263.3 Million |
| Forecasted Market Value ( USD | $ 327.1 Million |
| Compound Annual Growth Rate | 3.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
